Drug class
Lincosamide antibacterial; 50S ribosomal subunit inhibitor
Mechanism of action
Binds the 50S ribosomal subunit and inhibits bacterial protein synthesis by interfering with peptide-chain elongation and translocation.
General use cases
- Treatment of serious infections caused by susceptible Gram-positive bacteria and anaerobes when less toxic alternatives are inappropriate; route and indication are product- and jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
